Cbl-b−/− T Cells Demonstrate In Vivo Resistance to Regulatory T Cells but a Context-Dependent Resistance to TGF-β

Cbl-b is an E3 ubiquitin ligase that negatively regulates T cell activation. Cbl-b−/− mice develop spontaneous autoimmunity, and Cbl-b dysregulation has been described in both murine and human autoimmune diseases. Although the mechanisms underlying the development of autoimmunity in Cbl-b−/− mice are not yet clear, we have reported that Cbl-b−/− CD4+CD25− effector T cells (Teffs) are resistant to CD4+CD25+ regulatory T cell (Treg)-mediated suppression in vitro and have suggested that this may be an important mechanism in the development of autoimmunity. To confirm the relevance of this resistance to autoimmune disease, we now show that Cbl-b−/− Teffs are resistant to suppression by Tregs in vivo and that this involves a resistance of truly naive Cbl-b−/− Teffs. Additionally, we show that Cbl-b−/− Tregs are fully functional in vivo, further suggesting that the regulatory abnormalities in Cbl-b−/− mice are related to defects in Teff, not Treg, function. To characterize the relevance of TGF-β sensitivity in Treg resistance, we examined in vivo Th17 generation and report that Cbl-b−/− mice are able to mount a normal Th17 response in vivo. As Cbl-b−/− Teffs have been shown to be insensitive to the suppressive effects of TGF-β in other in vivo models, the present results suggest that Cbl-b−/− Teffs demonstrate a context-dependent sensitivity to TGF-β in vivo. Overall, our results suggest that resistance to Tregs may be a bona fide mechanism underlying autoimmunity and that Cbl-b−/− mice offer unique approaches for studying the interrelationships between Treg function, TGF-β–mediated responses, and the development of autoimmunity.

[1]  S. Zheng,et al.  Role of SMAD and Non-SMAD Signals in the Development of Th17 and Regulatory T Cells , 2010, The Journal of Immunology.

[2]  Casey T. Weaver,et al.  TGF-β Promotes Th17 Cell Development through Inhibition of SOCS31 , 2009, The Journal of Immunology.

[3]  T. Mak,et al.  Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies , 2009, Nature Medicine.

[4]  R. Flavell,et al.  T cell sensitivity to TGF-β is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber , 2009, International immunology.

[5]  B. Stockinger,et al.  The influence of CD4 T‐cell subsets on control of CD4 T‐cell‐mediated graft‐versus‐host disease , 2008, Immunology.

[6]  J. Buckner,et al.  The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells1 , 2008, The Journal of Immunology.

[7]  A. Ho,et al.  Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[8]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[9]  A. Yoshimura,et al.  Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads1 , 2008, The Journal of Immunology.

[10]  L. Turka,et al.  Allograft rejection mediated by memory T cells is resistant to regulation , 2007, Proceedings of the National Academy of Sciences.

[11]  Josef M. Penninger,et al.  Spontaneous tumor rejection by cbl-b–deficient CD8+ T cells , 2007, The Journal of experimental medicine.

[12]  V. Kuchroo,et al.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.

[13]  R. Clark,et al.  'Vive la Résistance!'--the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression. , 2007, Trends in immunology.

[14]  R. Hodes,et al.  Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. , 2007, The Journal of clinical investigation.

[15]  L. Hennighausen,et al.  Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. , 2007, Immunity.

[16]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[17]  L. Hennighausen,et al.  Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[19]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[20]  R. Flavell,et al.  Cutting Edge: Deficiency in the E3 Ubiquitin Ligase Cbl-b Results in a Multifunctional Defect in T Cell TGF-β Sensitivity In Vitro and In Vivo , 2006, The Journal of Immunology.

[21]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[22]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[23]  R. Gold,et al.  Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. , 2005, Cellular immunology.

[24]  L. Chatenoud,et al.  Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. , 2005, Diabetes.

[25]  R. Lechler,et al.  MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[26]  R. Coffman,et al.  T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[27]  J. Penninger,et al.  Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. , 2004, Immunity.

[28]  M. Callahan,et al.  Resistance to CD4+CD25+ Regulatory T Cells and TGF-β in Cbl-b−/− Mice , 2004, The Journal of Immunology.

[29]  Ethan M. Shevach,et al.  Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.

[30]  Michael Loran Dustin,et al.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins , 2004, Nature Immunology.

[31]  J. Bluestone,et al.  Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.

[32]  M. Naramura,et al.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation , 2002, Nature Immunology.

[33]  B. Blazar,et al.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.

[34]  Yun-Cai Liu,et al.  Proteolysis-independent regulation of PI3K by Cbl-b–mediated ubiquitination in T cells , 2001, Nature Immunology.

[35]  E. Shevach,et al.  Cbl-b regulates the CD28 dependence of T-cell activation , 2000, Nature.

[36]  H. Nishina,et al.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b , 2000, Nature.

[37]  E. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[38]  J. Sprent,et al.  Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells , 1994, The Journal of experimental medicine.

[39]  W. Walsh,et al.  The murine bm12 gene conversion provides evidence that T cells recognize predominantly Ia conformation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[40]  田中 謙太郎.  Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-γ on STAT3 and Smads , 2009 .

[41]  F. Jardin,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only. , 2006 .

[42]  M. Callahan,et al.  Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice. , 2004, Journal of immunology.